Original Source(s)
Related Content
AD Not Linked to Early CV Risk Markers
Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.
May 27, 2026
-
5 min
FDA Approves Less Frequent Lebrikizumab Dosing
Approval adds an every-8-week maintenance option for eligible patients with moderate-to-severe atopic dermatitis.
June 10, 2026
-
2 min